OverviewChartNewsTraderScreen

Soc. Generale Discount Zert EVT 2.../  DE000SW94P10  /

Frankfurt Zert./SG
20/09/2024  21:42:29 Chg.-0.060 Bid20/09/2024 Ask- Underlying Strike price Expiration date Option type
4.330EUR -1.37% 4.330
Bid Size: 4,000		 -
Ask Size: -		 EVOTEC SE INH O.N. - EUR 28/03/2025 Call
GlobeNewswire 14/05 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GlobeNewswire 11/12/2023 Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire 07/11/2023 Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire 20/08/2020 CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
GlobeNewswire 07/02/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 07/02/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 15/02/2018 EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire 08/01/2018 APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire 14/09/2017 MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
GlobeNewswire 29/11/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 10/11/2011 Evotec reports nine months results: Upside materialising
GlobeNewswire 03/11/2011 Evotec to Report Third Quarter Results on 10 November 2011
GlobeNewswire 27/10/2011 Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi
GlobeNewswire 20/10/2011 Evotec and APEIRON Biologics start next project on the Cbl-b target
GlobeNewswire 05/10/2011 Evotec announces second multi-target collaboration with UCB
GlobeNewswire 29/09/2011 Evotec acquires remaining 30% of Indian Joint Venture from DIL
GlobeNewswire 09/09/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 05/09/2011 Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease
GlobeNewswire 05/09/2011 Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...
GlobeNewswire 18/08/2011 Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...
GlobeNewswire 11/08/2011 Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised
GlobeNewswire 11/08/2011 Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company
GlobeNewswire 04/08/2011 Evotec to Report Second Quarter 2011 Results on 11 August 2011
GlobeNewswire 07/07/2011 Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases
GlobeNewswire 30/06/2011 Total voting rights:Evotec AG:Evotec AG: Publication pursuant to §26a WpHG (the German Securities Tr...